15 results on '"Furman, R"'
Search Results
2. FIRST RESULTS OF A HEAD‐TO‐HEAD TRIAL OF ACALABRUTINIB VERSUS IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
3. PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
4. A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukaemia Applicable to Patients Treated with Novel Therapies and Standard of Care
5. Results from the phase 2 RESONATE (TM)-17 Trial: Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic leukaemia with 17p deletion
6. Preparation of new reactive methylene monomers
7. The pathophysiology of myotonia produced by aromatic carboxylic acids
8. Molecular characteristics and functional reconstitution of muscle voltage-sensitive sodium channels
9. 20,25‐diazacholesterol myotonia: An electrophysiological study
10. Experiments with Sub-Surface Filters at Toledo, Ohio
11. Quantitative Studies of Phenols in Water Supply
12. ISOLATION AND CHARACTERIZATION OF HUMAN CHYLE CHYLOMICRONS AND LIPOPROTEINS
13. Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
14. Wrap-around services: an analysis of community-based mental health services for children.
15. Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.